KoreaMed Synapse

Go to TopGo to Top Go to BottomGo to Bottom


1	Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019 Jiyun Park, Gyuri Kim, Bong-Sung Kim, Kyung-Do Han, So Yoon Kwon, So Hee Park, You-Bin Lee, Sang-Man Jin, Jae Hyeon Kim Diabetes Metab J.2023;47(2):211-219. Published online 2023 February 7 DOI: http://dx.doi.org/10.4093/dmj.2022.0346

2	Machine Learning Approach to Drug Treatment Strategy for Diabetes Care Kazuya Fujihara, Hirohito Sone Diabetes Metab J.2023;47(3):325-332. Published online 2023 January 12 DOI: http://dx.doi.org/10.4093/dmj.2022.0349

3	Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won Diabetes Metab J.2023;47(1):82-91. Published online 2022 June 20 DOI: http://dx.doi.org/10.4093/dmj.2021.0356

4	Glucose-Lowering Agents and COVID-19 Ah Reum Khang J Korean Diabetes.2022;23(1):1-6. Published online 2022 March 31 DOI: http://dx.doi.org/10.4093/jkd.2022.23.1.1

5	2021 Korean Diabetes Association Clinical Practice Guidelines for Diabetes: Diabetic Kidney Disease Nam Hoon Kim J Korean Diabetes.2021;22(4):268-273. Published online 2021 December 31 DOI: http://dx.doi.org/10.4093/jkd.2021.22.4.268

6	Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019 Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park J Korean Med Sci.2021;36(36):e230. Published online 2021 August 6 DOI: http://dx.doi.org/10.3346/jkms.2021.36.e230

7	Recent Advances in Sodium Glucose Cotransporter-2 Inhibitors Dong Hyeok Cho J Korean Diabetes.2021;22(2):113-125. Published online 2021 June 30 DOI: http://dx.doi.org/10.4093/jkd.2021.22.2.113

8	Recent Perspective on Thiazolidinedione Won Jun Kim J Korean Diabetes.2021;22(2):97-104. Published online 2021 June 30 DOI: http://dx.doi.org/10.4093/jkd.2021.22.2.97

9	Psidium guajava L. leaf extract inhibits adipocyte differentiation and improves insulin sensitivity in 3T3-L1 cells Esther Choi, Seoyoung Baek, Kuanglim Baek, Hye-Kyeong Kim Nutr Res Pract.2021;15(5):568-578. Published online 2021 April 8 DOI: http://dx.doi.org/10.4162/nrp.2021.15.5.568

10	Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Xiaoling Cai, Chu Lin, Wenjia Yang, Lin Nie, Linong Ji Diabetes Metab J.2021;45(3):312-325. Published online 2021 March 15 DOI: http://dx.doi.org/10.4093/dmj.2020.0171

11	Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea Da Hea Seo, Kyoung Hwa Ha, So Hun Kim, Dae Jung Kim Endocrinol Metab.2021;36(1):70-80. Published online 2021 February 24 DOI: http://dx.doi.org/10.3803/EnM.2020.777

12	Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study Jun Sung Moon, Sunghwan Suh, Sang Soo Kim, Heung Yong Jin, Jeong Mi Kim, Min Hee Jang, Kyung Ae Lee, Ju Hyung Lee, Seung Min Chung, Young Sang Lyu, Jin Hwa Kim, Sang Yong Kim, Jung Eun Jang, Tae Nyun Kim, Sung Woo Kim, Eonju Jeon, Nan Hee Cho, Mi-Kyung Kim, Hye Soon Kim, Il Seong Nam-Goong, Eun Sook Kim, Jin Ook Chung, Dong-Hyeok Cho, Chang Won Lee, Young Il Kim, Dong Jin Chung, Kyu Chang Won, In Joo Kim, Tae Sun Park, Duk Kyu Kim, Hosang Shon Diabetes Metab J.2021;45(5):675-683. Published online 2020 August 12 DOI: http://dx.doi.org/10.4093/dmj.2020.0107

13	Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus Seung-Hyun Ko J Korean Diabetes.2019;20(3):142-148. Published online 2019 September 30 DOI: http://dx.doi.org/10.4093/jkd.2019.20.3.142

14	Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations Won Sang Yoo, Do Hee Kim, Hee Jin Kim, Hyun Kyung Chung J Korean Diabetes.2019;20(2):117-126. Published online 2019 June 30 DOI: http://dx.doi.org/10.4093/jkd.2019.20.2.117

15	The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes Gwang Sil Kim, Joong Hyun Park, Jong Chul Won Endocrinol Metab.2019;34(2):106-116. Published online 2019 May 9 DOI: http://dx.doi.org/10.3803/EnM.2019.34.2.106

16	Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management Silvia Pieralice, Paolo Pozzilli Diabetes Metab J.2018;42(6):451-464. Published online 2018 December 17 DOI: http://dx.doi.org/10.4093/dmj.2018.0190

17	Pharmacologic Treatment Using Non-Hypoglycemic Agents for Nonalcoholic Fatty Liver Disease Seung Up Kim J Korean Diabetes.2018;19(2):97-100. Published online 2018 June 27 DOI: http://dx.doi.org/10.4093/jkd.2018.19.2.97

18	Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats Muruganantham Koothappan, Roshana Devi Vellai, Iyyam Pillai Subramanian, Sorimuthu Pillai Subramanian Diabetes Metab J.2018;42(3):244-248. Published online 2018 April 24 DOI: http://dx.doi.org/10.4093/dmj.2018.0002

19	Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association Sang Youl Rhee J Korean Diabetes.2018;19(1):15-22. Published online 2018 January 10 DOI: http://dx.doi.org/10.4093/jkd.2018.19.1.15

20	Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Min Kyong Moon J Korean Diabetes.2018;19(1):23-30. Published online 2018 January 10 DOI: http://dx.doi.org/10.4093/jkd.2018.19.1.23